Fibrocell Science
Get Full AccessDescription
- Fibrocell is an autologous cell and gene therapy company translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. Fibrocells most advanced product candidate, FCX-007, has begun a Phase I/II trial for the treatment of recessive dystrophic epidermolysis bullosa (RDEB). Fibrocell is in pre-clinical development of FCX-013, its product candidate for the treatment of linear scleroderma. In addition, Fibrocell has a third program in the research phase for the treatment of arthritis and related conditions. Fibrocells gene-therapy portfolio is being developed in collaboration with Intrexon Corporation (NYSE: XON), a leader in synthetic biology. For more information, visit www.fibrocell.com or follow us on Twitter at @Fibrocell.
-
Headquarters:405 Eagleview Boulevard , Exton, Pennsylvania, United States
More -
Phone Number: +1 484-713-6000
-
Website: http://fibrocell.com/
-
Employees:29
-
Revenue:$10 - 50M
-
Legal Name:Fibrocell Science
-
Fibrocell Science's Social Media
-
Is this data correct?
-
| NAICS Code: 541720 |
Show More
Frequently Asked Questions regarding Fibrocell Science
-
Where are Fibrocell Science's Headquarters?
Fibrocell Science's Headquarters are in 405 Eagleview Boulevard ,Exton,Pennsylvania,United States
-
What is Fibrocell Science's phone number?
Fibrocell Science's phone number is +1 484-713-6000
-
What is Fibrocell Science's official website?
Fibrocell Science's official website is http://fibrocell.com/
-
What is Fibrocell Science's Revenue?
Fibrocell Science's revenue is $10 - 50M
-
What is Fibrocell Science's NAICS code?
Fibrocell Science's NAICS code is 541720
-
How many employees are working in Fibrocell Science
Fibrocell Science has 29 employees
-
What is Fibrocell Science's Industry?
Fibrocell Science is in the industry of Biotechnology
-
Who is Fibrocell Science's Director?
Fibrocell Science's Director is Barbara Swift

